Prostate Cancer Screening (PSA Test)
The PSA blood test can find prostate cancer early — but it also finds cancers that would never have caused harm. For men 55 to 69 the USPSTF calls screening an individual decision (grade C); at 70 and over it recommends against it (grade D).

Prostate cancer screening uses a blood test for PSA (prostate-specific antigen), a protein made by the prostate. A raised PSA can be a sign of cancer — but it is also raised by benign prostate enlargement, infection, and other non-cancer causes.
This is the screening topic where the balance of benefits and harms is closest, and the USPSTF is explicit about it: for men aged 55 to 69, screening is a grade C service — an individual decision made after discussing the benefits and harms with your clinician. For men aged 70 and over, the Task Force recommends against screening (grade D). This page sets out both sides, as the Task Force presents them.
What this screening checks
- The PSA level in your blood. PSA is a risk marker, not a cancer test: most men with a raised PSA do not have cancer.
- A digital rectal examination (DRE) is sometimes done in clinics, but the USPSTF does not recommend it as a screening test on its own.
Who should have it, and how often
Men aged 55 to 69: discuss PSA screening with your clinician and decide together, based on your values and your individual risk.
Men aged 70 and over: screening is not recommended (grade D) — the potential harms outweigh the small potential benefit at older ages.
Risk is higher with older age, African American (Black) ancestry, and a family history of prostate cancer. If that is you, raise the conversation with your clinician earlier rather than waiting.
Urinary symptoms — a weak flow, getting up at night, difficulty starting — are usually caused by benign prostate enlargement, not cancer, but they deserve a diagnostic visit either way.
What happens during the test
- PSA screening is a simple blood test, usually taken from a vein in the arm.
- If the PSA is raised, your clinician may repeat the test first, because levels can be temporarily high for other reasons.
- Persistent or worrying results can lead to an MRI scan of the prostate, and then possibly a biopsy — taking small tissue samples through the rectum or the perineum — which is the only way to confirm cancer.
How to prepare
- No fasting is needed for a PSA test.
- Tell the clinician about anything that can affect PSA: a recent urine infection or prostate procedure, and medicines for prostate enlargement or hair loss, which can lower the reading.
- The most important preparation is the conversation itself: read the benefits and harms below before you decide.
What the results mean
A normal PSA is reassuring but does not rule out prostate cancer completely. A raised PSA starts a process — usually a repeat test, then possibly imaging or biopsy — rather than giving an answer by itself.
If a biopsy finds cancer, it is graded by how aggressive it looks. Many screen-detected cancers are slow-growing, and for low-risk cancers, monitoring ('active surveillance') instead of immediate treatment is a standard option to discuss.
Benefits
- A small potential benefit in preventing death from prostate cancer: the USPSTF estimates about 1.3 deaths prevented per 1,000 men screened over about 13 years.
- Screening may also prevent a small number of cases of cancer spreading (metastatic disease).
- Some men value knowing, even given the downsides — that preference is a legitimate part of the decision.
Limits and possible harms
- False positives: a raised PSA without cancer can lead to biopsy, which carries risks of infection, bleeding and urinary problems.
- Overdiagnosis: screening finds cancers in an estimated 20 to 50 percent of screen-detected cases that would never have caused symptoms or death — but once found, they are often treated.
- Treatment harms: surgery and radiotherapy for prostate cancer can cause urinary incontinence and erectile dysfunction.
- Anxiety from an abnormal result, and from living with a monitored low-risk cancer.
Useful links and tools
More in Cancer Screening
- Breast Cancer Screening (Mammogram)
- Cervical Cancer Screening (Pap & HPV Tests)
- Colorectal Cancer Screening (Colonoscopy & Stool Tests)
- Lung Cancer Screening (Low-Dose CT)
Frequently asked questions
Should I have a PSA test?
There is no single right answer — that is exactly why the USPSTF grades screening C (an individual decision) for men 55 to 69. Screening offers a small potential reduction in prostate cancer deaths, set against common false alarms and a real risk of finding and treating cancers that would never have harmed you. Read both lists on this page and decide with your clinician; at 70 and over, the Task Force recommends against screening.
My PSA is raised. Does that mean I have prostate cancer?
Usually not. PSA rises with benign prostate enlargement, infection, inflammation and other causes, and most men with a raised PSA do not have cancer. The usual next step is to repeat the test, and only persistent or concerning results lead toward an MRI scan or a biopsy, which is what actually diagnoses cancer.
This guide explains how a screening test usually works and who it is generally offered to. It is general educational information only — not medical advice, and not a recommendation for you personally. Screening decisions depend on your age, history and risk, so talk to your own clinician about which tests you need and when. If you have symptoms now, do not wait for a screening test — seek medical care promptly.